Corruption Category Access to medicines, vaccines and other products
Anti-corruption work relating to the production, supply, distribution, sale and marking of medicines, vaccines and other healthcare products. To prevent theft and safe products, the supply chain should be well designed and have robust checks and balances.
Transparency and Professionalism of Drug Reimbursement Policy
Slovakia spent a total of €1.1 billion of public money in 2015 on medicines (reimbursed to health insurance companies). This is more than the annual budgets for the Ministries of Defence and Culture combined. The categorisation of medicines is a key part of the decision-making process on drug expenditure. The health care system decides whether…
Sectoral Risk Assessment in Sri Lanka
The Sustainable Development Goal 3 concerning health was viewed from 3 different dimensions; mapping of the different stakeholders in the particular sector, identifying the types of corruption and the most prevalent practices of corruption in the sector, identifying gaps in the legal framework.
Management Of Conflicts Of Interest In Healthcare And Pharmaceutical Industry Cooperation
The research explored the potential conflicts of interest faced by doctors working with the pharmaceutical industry and at the same time involved in the categorisation of medicines - deciding which medicines to pay from public health insurance sources (risks of biased drug decisions).
Governance of the Directorate of Drug Administration: Challenges and Way forward
The study by TI-Bangladesh has assessed the effectiveness of the Government Drug Administration to tackle corruption. The study follows recent measures by the Government to strengthen the capacities of the Drug Administration. These include an increase of work force in field offices and measures to construct central drug laboratory and its capacity building. Moreover, it…
TI Lithuania launched a social design experiment "Vitamin Lab" to see if changing clinic’s environment indirectly affects the behaviour and attitudes of patients, increase transparency and reduce bribery.
Vitamin Lab featured an interactive installation that TI Lithuania created with the community of Lazdynai Outpatient Clinic. Installed in the clinic’s waiting area, every patient was invited to evaluate his/her visit and indicate how smoothly the procedures went, how clear the doctor was when prescribing medication, what the overall impression of the visit was, would they be willing to say thank you to their doctor.
Patients expressed their feedback by distributing five yellow tokens into different categories of evaluation e.g. procedures were clear; communication was pleasant; I did not like it.
Transparency Tools for the Private Sector: Promoting Tools to Improve Transparency Standards in the Pharmaceutical Sector – Multi-Sectorial Transparency Agreement
To promote transparency in the pharmaceutical sector.
i) to provide a space for knowledge sharing and networking, with a view of setting up an agenda for multi-stakeholder collaboration and increase transparency in the pharmaceutical sector;
ii) to establish a guide outlining principles to strengthen transparency in the sector, which would support the signing of multi-stakeholder transparency agreements (MTA);
iii) to promote synergies among all relevant actors within the pharmaceutical sector
Improve Transparency and Accountability in Health Sector under Building Integrity Blocks for Effective Change (BIBEC) Project
Transparency International Bangladesh's work on health issues mainly includes research and advocacy at local and national levels. The main objective of these activities is to bring about positive changes in policies and practices of concerned authorities in regard to ensuring good governance and integrity in health services.
Fight against Illicit Trade of Pharmaceutical Products.
Raising public awareness of the impact of counterfeit drugs and medicines on their health.
Advocating for law enforcement operations to increase the seizure of counterfeit medical products.
Enhancing Community Awareness on the Linkage between Corruption and Human Rights
Based on The Coalition for Accountability and Integrity (AMAN) continuous search and analysis, the link between corruption and enjoyment of human rights is not yet recognized by different actors of the Palestinian society including official and non-official organizations, mainly those who are working in the field of anti-corruption and human rights.
Thus, AMAN worked throughout this project on sharing the global knowledge on this linkage by compiling a practical assessment for Palestine with focus on the fundamental right to health, and providing community awareness on this linkage and empowering CSOs working on the health right to integrate integrity, transparency, accountability and anti- corruption in their strategies to play an active role in holding officials accountable for corruption and violation of human rights.
Community and Health Provider-driven Social Accountability Intervention (CaPSAI)
The Community and Provider-driven Social Accountability Intervention (CaPSAI) study is an intervention initiated in partnership with the UNDP, UNFPA, UNICEF, WHO and the World Bank Special Training in Human Reproduction (HRP Research), which is the main instrument and leading research agency within the United Nations system concerned with sexual and reproductive health and rights.
It is being implemented by Ghana Integrity Initiative (GII) and Population Council, with the aim of assessing how social accountability mechanisms can influence contraceptive uptake and use in family planning programmes/uptake.
The project is implemented in three district and in eight health sites (communities) in the Central region of Ghana.
The methodology adopted to implement this social accountability, is the use of community scorecard and eight steps has been designed to follow:
• Introduction of the intervention to the community.
• Mobilization of participants for the intervention.
• Health, rights and civic education with community participants.
• Prioritization meeting with community.
• Prioritization meeting with duty bearers.
• Interface meeting and joint action planning.
• First follow-up meeting with community and duty bearers at three months.
• Second follow-up meeting with community duty bearers at six months.
Global Partners:Department for International Development UK (DIFD) Swedish International Development Cooperation Agency (SIDA) Novartis
Hospital Health Management Committees
Ministry of Health
NGO or Civil Society Organisation
Healthcare Clinics in Lithuania
Individuals or general public